Siemens Showcases Broad Portfolio of Integrated IVD Solutions at EUROMEDLAB Munich
|
By LabMedica International staff writers Posted on 11 Apr 2022 |
|
Siemens Healthineers (Erlangen, Germany) showcased its broad portfolio of integrated IVD solutions at EUROMEDLAB 2022 which was held 10th-14th April 2022 in Munich, Germany.
At EUROMEDLAB Munich, Siemens demonstrated it automation solutions for labs of all sizes that are fully scalable, innovative, and customized for individual workflows. Siemens demonstrated how labs could achieve open, one-touch, end-to-end testing with its Aptio Automation solution and drive open, one-touch sample preparation for multidisciplinary labs with its Atellica Task Targeted Automation solution. The company also demonstrated how its Atellica Integrated Automation solution could streamline the biggest chemistry and immunoassay workloads for laboratories.
The company showcased its two new high-volume hematology analyzers - Atellica HEMA 570 and 580 - designed to meet the hematology testing needs of today’s high-volume labs. Sharing fast throughput and an identical footprint, both instruments are intended to pair with advanced informatics and automation solutions to suit diverse workflow requirements and drive efficiencies across labs and networks. Each delivers a range of analytical capabilities, including an 8-part white blood cell differential, with the Atellica HEMA 580 Analyzer offering an expanded menu complete with optical platelet and reticulocyte testing. In addition, Siemens highlighted its epoc Blood Analysis System with epoc NXS Hos, the market-first Android powered patient-side testing solution. epoc is a handheld, wireless solution to enable comprehensive blood analysis testing at the patient’s side on a single room temperature test card, with results in less than a minute.
Siemens also displayed the Dimension EXL 200 Integrated Chemistry System which can simplify operations with an integrated chemistry and immunoassay analyzer in a compact footprint. Also on display were the Sysmex CN-3000 and CN-6000 fully automated, mid- and high-volume coagulation analyzers that are designed to tackle big lab challenges. In addition, Siemens exhibited the new Atellica DCA connected, scalable, and portable analyzer that can collect actionable HbA1c and ACR results in minutes, alongside the Atellica CI 1900 System which is being developed for lower- to mid-volume laboratories. Among its high-performing assays, Siemens showcased the breadth and depth of its clinical menu from cardiac and allergy testing to dedicated plasma protein/FLC to real-time PCR testing for SARS-CoV-2, new preeclampsia markers and more.
Related Links:
Siemens Healthineers
Latest EUROMEDLAB 2022 News
- Sebia Displays Automated, High Throughput Capillary Electrophoresis (CE) Instruments at EUROMEDLAB 2022
- Snibe Showcases Maglumi X3 Fully Automatic CLIA System at EUROMEDLAB 2022
- Thermo Fisher Presents Cascadion SM Clinical Analyzer and LC-MS IVD Medical Devices at EUROMEDLAB 2022
- Binding Site Exhibits Special Protein Analyzer Optilite at EUROMEDLAB 2022
- DIRUI Presents High-End Diagnostic Systems for Hospitals and High-Volume Labs at EUROMEDLAB 2022
- DIESSE Diagnostica Demonstrates Advanced Immunoassay and ESR Analyzers at EUROMEDLAB 2022
- Gentian Diagnostics Exhibits Assays for Wide Range of Clinical Chemistry Platforms at EUROMEDLAB
- Ortho Presents Broad Menu of High-Performing Assays at EUROMEDLAB 2022
- Technopath Highlights Laboratory Solutions to Enhance QC Efficiencies at EUROMEDLAB 2022
- Mindray Demonstrates Latest IVD Innovations at EUROMEDLAB 2022
- LumiraDx Presents LumiraDx Point of Care Instrument at IFCC EUROMEDLAB
- Beckman Coulter Presents Virtual Showcase of Laboratory Solutions at EUROMEDLAB 2022
- Horiba Showcases Latest Hematology and Hemostasis Solutions at EUROMEDLAB 2022
- Sysmex Europe Exhibits New Products and Innovative Concepts in Infection Diagnostics at EUROMEDLAB 2022
- Roche Showcases the Future of Diagnostic Solutions at EUROMEDLAB 2022
- EUROMEDLAB 2022 Showcases Breakthrough Technologies and Cutting Edge Scientific Advances in Clinical Lab Diagnostics
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
Molecular Diagnostics
view channel
Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
Approximately one in three women aged 14-49 in the United States will experience bacterial vaginosis (BV), a vaginal bacterial imbalance, at some point in their lives. Around 50% of BV cases do not present... Read more
Rapid Diagnostic Test to Halt Mother-To-Child Hepatitis B Transmission
Hepatitis B, an inflammation of the liver caused by the hepatitis B virus (HBV), is the second-leading infectious cause of death globally, following tuberculosis. This viral infection can result in serious... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Cerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Pathology
view channel
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read more
Technology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read more
Industry
view channel
Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
Royal Philips (Amsterdam, The Netherlands) has expanded its partnership with Ibex Medical Analytics (Tel Aviv, Israel) and released the new Philips IntelliSite Pathology Solution (PIPS) to further accelerate... Read more
Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
Grifols (Barcelona, Spain), a manufacturer of plasma-derived medicines and innovative diagnostic solutions, has entered into a strategic agreement with Inpeco (Novazzano, Switzerland), a global leader... Read more
